| Product Code: ETC6457283 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Overview |
3.1 Bosnia and Herzegovina Country Macro Economic Indicators |
3.2 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Revenues & Volume, 2021 & 2031F |
3.3 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market - Industry Life Cycle |
3.4 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market - Porter's Five Forces |
3.5 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bronchopulmonary dysplasia in infants in Bosnia and Herzegovina |
4.2.2 Growing awareness about the condition among healthcare professionals and parents |
4.2.3 Technological advancements in the diagnosis and treatment of bronchopulmonary dysplasia |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities in certain regions of Bosnia and Herzegovina |
4.3.2 High cost associated with advanced treatments for bronchopulmonary dysplasia |
4.3.3 Lack of standardized protocols for the management of the condition |
5 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Trends |
6 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market, By Types |
6.1 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Revenues & Volume, By Pneumostem, 2021- 2031F |
6.1.4 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Revenues & Volume, By UMC 119 01, 2021- 2031F |
6.1.5 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Revenues & Volume, By AT 100, 2021- 2031F |
6.1.6 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Revenues & Volume, By OHB-607, 2021- 2031F |
7 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Import-Export Trade Statistics |
7.1 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Export to Major Countries |
7.2 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Imports from Major Countries |
8 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Key Performance Indicators |
8.1 Average age of bronchopulmonary dysplasia diagnosis in infants |
8.2 Number of healthcare professionals trained in the diagnosis and treatment of bronchopulmonary dysplasia |
8.3 Percentage of infants with bronchopulmonary dysplasia receiving appropriate treatment |
9 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market - Opportunity Assessment |
9.1 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market - Competitive Landscape |
10.1 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Revenue Share, By Companies, 2024 |
10.2 Bosnia and Herzegovina Bronchopulmonary Dysplasia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |